Palombella Vito J. 4
4 · Surface Oncology, Inc. · Filed Feb 5, 2020
Insider Transaction Report
Form 4
Palombella Vito J.
Chief Scientific Officer
Transactions
- Award
Common Stock
2020-02-03+80,000→ 80,000 total - Award
Stock Option (Right to Buy)
2020-02-03+80,000→ 80,000 totalExercise: $3.18Exp: 2030-02-03→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in full on the date 18 months after January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such date.
- [F2]This option shall become exercisable in equal monthly installments over four years following January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such dates.